Mar 27, 2009 - Teva Pharmaceutical Industries Ltd. announced today that the U.S. FDA granted approval for the Company's Abbreviated New Drug Application to market its generic version for Ortho-McNeil's anticonvulsant Topamax (Topiramate) Tablets, 25 mg, 50 mg, 100 mg and 200 mg. Shipment of this product has commenced.
The details can be read here.
No comments:
Post a Comment